Literature DB >> 24839489

Salvage Holmium laser enucleation of prostate to treat residual benign prostatic hyperplasia.

Jin Kyu Oh1, Jungbum Bae2, Chang Wook Jeong3, Jae-Seung Paick3, Seung-June Oh3.   

Abstract

INTRODUCTION: The Holmium laser enucleation of the prostate (HoLEP) technique to remove residual adenoma has not been reported. Salvage HoLEP enables anatomical enucleation of residual adenoma in patients who have previously undergone surgical treatment. We describe not only anatomical insights into the frequent location of adenoma recurrence, but also the feasibility of the salvage HoLEP technique.
METHODS: We retrospectively reviewed a database containing HoLEP video records for 35 patients out of a total of 535 individuals on whom HoLEP was performed by 2 surgeons (SJO & JSP) between July 2008 and June 2011. Group 1 consisted of patients who underwent salvage HoLEP due to recurring adenoma and Group 2 of patients who underwent HoLEP as an initially surgical management to treat benign prostate hyperplasia (BPH). We compared the dataset of pre-, intra- and postoperative parameters between Groups 1 and 2.
RESULTS: In the analysis of the video records of Group 1 (n = 35), there was significant remnant tissue around the verumontanum and the lateral lobes were also incompletely removed by previous conventional procedures. When we compared pre-, intra- and postoperative parameters between the 2 groups, there were no significant differences, including operation time, duration of hospital stay. However, the duration of the catheterization of Group 1 was shorter than that of Group 2 (1.38 ± 0.55 vs. 1.90 ± 1.81 days, p < 0.001).
CONCLUSIONS: Even for cases of residual BPH, salvage HoLEP is a feasible and effective procedure for treating residual adenoma along the anatomical plane.

Entities:  

Year:  2014        PMID: 24839489      PMCID: PMC4001650          DOI: 10.5489/cuaj.1494

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN: 1911-6470            Impact factor:   1.862


  17 in total

Review 1.  Is transurethral resection of the prostate still justified?

Authors:  S Madersbacher; M Marberger
Journal:  BJU Int       Date:  1999-02       Impact factor: 5.588

Review 2.  Current role of lasers in the treatment of benign prostatic hyperplasia (BPH).

Authors:  Rainer M Kuntz
Journal:  Eur Urol       Date:  2006-03-31       Impact factor: 20.096

3.  Complications of transurethral resection of the prostate (TURP)--incidence, management, and prevention.

Authors:  Jens Rassweiler; Dogu Teber; Rainer Kuntz; Rainer Hofmann
Journal:  Eur Urol       Date:  2006-01-30       Impact factor: 20.096

4.  Mortality and reoperation after open and transurethral resection of the prostate for benign prostatic hyperplasia.

Authors:  N P Roos; J E Wennberg; D J Malenka; E S Fisher; K McPherson; T F Andersen; M M Cohen; E Ramsey
Journal:  N Engl J Med       Date:  1989-04-27       Impact factor: 91.245

5.  Holmium laser enucleation of prostate for benign prostatic hyperplasia: seoul national university hospital experience.

Authors:  Jungbum Bae; Minsoo Choo; Ji Hyun Park; Jin Kyu Oh; Jae-Seung Paick; Seung-June Oh
Journal:  Int Neurourol J       Date:  2011-03-30       Impact factor: 2.835

Review 6.  Holmium laser enucleation of the prostate: morbidity in a series of 206 patients.

Authors:  Ramsay L Kuo; Ryan F Paterson; Tibério M Siqueira; Stephanie L Watkins; Garrick R Simmons; Ronald E Steele; James E Lingeman
Journal:  Urology       Date:  2003-07       Impact factor: 2.649

7.  Long-term predictive role of urodynamics: an 8-year follow-up of prostatic surgery for lower urinary tract symptoms.

Authors:  K M Jensen; T B Jørgensen; P Mogensen
Journal:  Br J Urol       Date:  1996-08

8.  Holmium laser resection of the prostate: preliminary results of a new method for the treatment of benign prostatic hyperplasia.

Authors:  P J Gilling; C B Cass; M D Cresswell; M R Fraundorfer
Journal:  Urology       Date:  1996-01       Impact factor: 2.649

Review 9.  Systematic review and economic modelling of effectiveness and cost utility of surgical treatments for men with benign prostatic enlargement.

Authors:  T Lourenco; N Armstrong; J N'Dow; G Nabi; M Deverill; R Pickard; L Vale; G MacLennan; C Fraser; S McClinton; S Wong; A Coutts; G Mowatt; A Grant
Journal:  Health Technol Assess       Date:  2008-11       Impact factor: 4.014

Review 10.  Minimally invasive treatments for benign prostatic enlargement: systematic review of randomised controlled trials.

Authors:  Tania Lourenco; Robert Pickard; Luke Vale; Adrian Grant; Cynthia Fraser; Graeme MacLennan; James N'Dow
Journal:  BMJ       Date:  2008-10-09
View more
  3 in total

1.  Does prior transurethral resection of prostate have a negative impact on the outcome of holmium laser enucleation of prostate? Results from a prospective comparative study.

Authors:  Usama Khater; Nicholas Anthony Smith; Jonathan E Katz; Abhishek Bhat; Indraneel Banerjee; Rashmi H Shah; Hemendra N Shah
Journal:  Urol Ann       Date:  2022-02-17

2.  Measuring change in prostate size after holmium laser enucleation: A prospective study.

Authors:  Jin Kyu Oh; Kwang-Pil Ko; Seung-June Oh
Journal:  Investig Clin Urol       Date:  2017-04-05

3.  Outcomes of Top-Down Holmium Laser Enucleation of Prostate for Recurrent/Residual Benign Prostatic Hyperplasia: One-Year Follow-Up.

Authors:  Ahmed S Zakaria; Amr Hodhod; Loay Abbas; Moustafa Fathy; Ruba Abdul Hadi; Waleed Shabana; Anastasia Alexandra MacDonald; Ahmed Gamaleldin; Mohamed Abdallah; Mohamed Elgharbawy; Abdulrahman Ahmad; Adam Roos; Ahmed Kotb; Walid Shahrour; Hazem Elmansy
Journal:  Adv Urol       Date:  2022-09-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.